Please use this identifier to cite or link to this item: http://hdl.handle.net/11452/25802
Title: Pulmonary actinomycosis mimicking metastasis from lung adenocarcinoma
Authors: Uludağ Üniversitesi/Tıp Fakültesi/Tıbbi Onkoloji Anabilim Dalı.
Uludağ Üniversitesi/Tıp Fakültesi/Patoloji Anabilim Dalı.
Uludağ Üniversitesi/Tıp Fakültesi/İç Hastalıkları Anabilim Dalı.
0000-0002-9732-5340
0000-0003-0298-4157
Ölmez, Ömer Fatih
Çubukçu, Erdem
Evrensel, Türkkan
Kanat, Özkan
Kurt, Ender
Akyıldız, Elif U.
Coşkun, Belkıs Nihan
Manavoğlu, Osman
AAJ-1027-2021
AAG-7155-2021
26435400000
53986153800
6603942124
55881548500
7006207332
55383413100
55646165400
6602587152
Keywords: Oncology
Actinomycosis
Adenocarcinoma
Pulmonary
Issue Date: Oct-2012
Publisher: Karger
Citation: Ölmez, Ö. F. vd. (2012). "Pulmonary actinomycosis mimicking metastasis from lung adenocarcinoma". Onkologie, 35(10), 604-606.
Abstract: Background: Pulmonary actinomycosis may create a diagnostic and therapeutic dilemma especially in cancer patients. Case Report: A 64-year-old male patient presented with a productive cough, bloody sputum, and weight loss. Thoracic computed tomography (CT) showed a 5-cm mass in the upper lobe of the right lung, and a 2-cm mass in the lower lobe of the left lung. Bronchoscopic examination did not show any endobronchial lesions. CT-guided needle biopsy of the right pulmonary lesion showed lung adenocarcinoma. Whole-body positron emission tomography/CT revealed an increase in fluorodeoxyglucose accumulation in the upper lobe of the right lung, in the lower lobe of the left lung, and in the right hilar and paratracheal lymph nodes. Before chemotherapy was initiated, the patient had to be admitted to the hospital because of massive hemoptysis. Bronchoscopic examination indicated persistent bleeding in the left lower lobe bronchus. The patient underwent diagnostic left thoracotomy, and wedge resection of the lower lobe mass. The diagnosis was pulmonary actinomycosis, and the patient received oral amoxicillin. He underwent successful surgery for the primary disease following 6 cycles of chemotherapy. Conclusion: Oncologists should be aware of rare diseases that may affect management approaches in the treatment of cancer.
URI: https://doi.org/10.1159/000342675
https://www.karger.com/Article/Abstract/342675
http://hdl.handle.net/11452/25802
ISSN: 0378-584X
Appears in Collections:Scopus
Web of Science

Files in This Item:
There are no files associated with this item.


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.